Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where Altshuler sold a total of 10,149 shares, grossing $4,271,809.92.
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where Altshuler sold a total of 10,149 shares, grossing $4,271,809.92.